Quantifying nociception could clarify the sites of action of analgesics. For example, in the ®eld of thoracic analgesia, there has been debate about interpleural local anaesthetics. Whether action is by diffusion to intercostal nerves or on pleural sites that also feed nociception along the phrenic and vagus nerves could be demonstrated with a disaggregation methodology.
Quantifying nociception could clarify the sites of action of analgesics. For example, in the ®eld of thoracic analgesia, there has been debate about interpleural local anaesthetics. Whether action is by diffusion to intercostal nerves or on pleural sites that also feed nociception along the phrenic and vagus nerves could be demonstrated with a disaggregation methodology.
And it is not only local anaesthetic pharmacodynamics to which pain disaggregation theory could be applied. The observation that the fentanyl group were discomforted more by arm movement than coughing, in comparison to those who had intercostal nerve block or systemic opioid, is probably a re¯ection of the small numbers in the former and not repeatable. But it may have other signi®cance. That fentanyl suppresses the cough re¯ex can be discounted. The cough manoeuvre was contrived for the studies and is not a natural observation. A distant possibility is that the dynamic pain scoring technique has shown a marker for a segmental action of opioids such as fentanyl. Also, a new problem is emerging in clinical practice ± that of acute tolerance to opioids following the intraoperative use of remifentanil. The descriptions of the pain experiences of some of these patients are new and there is anecdotal evidence of disaggregation phenomena to such an extent that old operations are requiring the application of novel multimodal analgesic regimens.
Applying the logic that follows from a theory based on quantum nociception extends to clari®cation of the activity of a third component of multimodal regimens: the nonsteroidal anti-in¯ammatory drugs. Current belief is that these drugs reduce a`nocigenic soup' of in¯ammatory mediators. This may be a quanti®able reduction measurable with double-blind, placebo-controlled methodology. The effect and in¯uence of pre-emptive techniques on postoperative pain could similarly be measured. Therefore, it is to be hoped that, besides enlightening the science of clinical analgesia, a paradigm of quantum nociception ultimately will lead to improvements in patient care. skeletal muscle, result from central serotonergic overstimulation or from a porcine stress syndrome remains unresolved. In this study the in vivo effects of DOI on anaesthetized (and thus stress-protected) MHS and MH-normal (MHN) pigs were investigated.
Methods and results. DOI 1 mg kg ±1 was administered three times at 40-min intervals to ®ve MHS and ®ve MHN anaesthetized pigs. Body temperature, heart rate, muscle tone, arterial carbon dioxide pressure (Pa CO 2 ), pH and creatine kinase concentrations were measured. The clinical occurrence of MH was de®ned by Pa CO 2 above 70 mm Hg and an increase in body temperature of more than 2°C. Intragroup differences were analysed with the Friedman test as an overall non-parametric ANOVA and, in case of signi®cance, with the Wilcoxon test. Intergroup comparisons were performed with the Mann±Whitney U-test (statistical signi®cance P<0.05). MHS and MHN pigs developed muscle fasciculations, signi®cant increases in body temperature and Pa CO 2 and a signi®cant decrease in pH after the administration of DOI. These changes were comparable in both groups until the third dose of DOI, when in MHS pigs heart rate and Pa CO 2 rose signi®cantly and pH fell signi®cantly compared with MHN pigs. All MHS pigs ful®lled the MH criteria. Body temperature increased by more than 2°C in all MHN pigs and Pa CO 2 exceeded 70 mm Hg in two. Thus, two MHN pigs ful®lled the criteria of MH.
Conclusions. The comparability of the clinical presentation following DOI administration in MHS and MHN animals and the order of the development of MH-like symptoms favour the hypothesis of a central serotonergic overstimulation, leading to a serotonin syndrome. Various studies indicate a potential in¯uence of serotoninergic mechanisms in the development of malignant hyperthermia (MH).
1±4 Following administration of the hallucinogenic serotonin-2 5HT 2A receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride (DOI) in conscious MH-susceptible (MHS) pigs, behavioural alterations, muscle rigidity, hyperthermia and metabolic alterations were observed, which were interpreted as MH. 5 It is not known, however, whether these alterations were mediated by speci®c effects on the skeletal muscle cell, resulting in an MH crisis, or resulted from a central overstimulation eliciting a serotonin syndrome and/or from an hallucinogen-induced psychosis starting a porcine stress syndrome.
This study was designed to identify the in vivo effects of DOI on anaesthetized MHS and MH normal (MHN) pigs. In this experimental setting, a hallucinogen-induced stress reaction is excluded by anaesthesia to enable differentiation between MH and serotonin syndrome.
Methods and results
After approval of the local animal research committee, ®ve MHN (German Landrace pigs, aged 4±6 months, weighing 39±48 kg) and ®ve MHS pigs (Pietrain pigs, aged 4±5 months, weighing 26±33 kg) were investigated. The pigs were premedicated with azaperone 4 mg kg ±1 i.m. and metomidate 10 mg kg ±1 intraperitoneally. General anaesthesia was induced with etomidate 0.3 mg kg ±1 and fentanyl 10 mg kg ±1 and maintained with etomidate 2.5 mg kg ±1 h ±1 , fentanyl 50 mg kg ±1 h ±1 and nitrous oxide 66% in oxygen. After tracheal intubation, the lungs were ventilated mechanically. Neuromuscular blocking agents were not administered. A central venous catheter and an arterial cannula were placed. Radiant heat and warming blankets guaranteed normothermia during the baseline period. Rectal temperature was measured continuously. A blood gas analyser (ABL625, Radiometer, Denmark) was used to monitor Pa CO 2 and pH. Creatine kinase concentrations in venous plasma were measured using standard laboratory methods.
Mechanical ventilation was adjusted to maintain Pa CO 2 at 40 (SD 2) mm Hg until the experiment started. Once a steady state was achieved for 30 min, baseline values for all variables were recorded. Three doses of DOI 1 mg kg ±1 i.v. were administered at 40-min intervals. Variables were measured every 10 min. After completion of all tests the animals were killed by i.v. magnesium chloride.
Statistical analysis was performed using SPSS â 10.0 (SPSS Inc., USA). Data are presented as medians and ranges. As an overall non-parametric ANOVA, the Friedman test for the analysis of intragroup variations was used. In cases of signi®cance, we compared the baseline values with each time point using the Wilcoxon test. The intergroup analysis was performed with the non-parametric Mann± Whitney U-test. P<0.05 indicated statistical signi®cance.
The median body temperature in MHS pigs before the ®rst dose of DOI was 36.6 (range 35.8±38.5)°C. The temperature increased to 37.7 (36.9±39.6)°C 40 min after the ®rst dose of DOI, 38.9 (38.3±42.1)°C 40 min after the second dose and 41.5 (40.2±41.9)°C 40 min after the last dose. MHN animals had a baseline body temperature of 37.8 (35.7±39.1)°C. The temperature increased to 38.7 (36.5± 39.7)°C 40 min after the ®rst dose of DOI, 39.6 (37.6±40.7)°C 40 min after the second dose and 40.3 (38.1±41.5)°C 40 min after the last dose. Statistical analysis showed a signi®cant temperature increase in the MHS and MHN groups, but no signi®cant intergroup variations.
Pa CO 2 increased signi®cantly in both groups ( Fig. 1 ) but there was a signi®cant difference between the two groups only after the third dose of DOI.
The ®rst dose of DOI induced a signi®cant decrease in pH from 7.46 (7.42±7.47) to 7.30 (7.26±7.38) in the MHS group. The second dose decreased pH to 7.24 (7.05±7.32) and the third to 7.13 (6.84±7.17). The pH values decreased signi®cantly after the ®rst dose in the MHN pigs from 7.49 (7.41±7.56) to 7.35 (7.31±7.44), but remained virtually unchanged for the rest of the experiment. The intergroup comparisons showed a signi®cant difference in pH after 120 min only.
In the MHS pigs, heart rate rose signi®cantly from the baseline value of 60 (55±94) beats min ±1 to 66 (61±91) beats min ±1 after the ®rst DOI dose, 85 (65±205) beats min ±1 after the second dose and 115 (87±174) beats min ±1 after the third dose. In contrast, no signi®cant changes in heart rate occurred in MHN pigs. After 120 min, however, a signi®cant difference in heart rate was found between the groups.
Non-signi®cant but higher baseline creatine kinase concentrations were measured in MHS pigs (median 7.7 u litre ±1 , range 5.5±18.9 u litre ±1 ) compared with MHN pigs (4.8 u litre ±1 , 4.2±8.1 u litre ±1 ). In both groups, the cumulative challenge of DOI exerted only slight effects on creatine kinase activity. Both MHS and MHN pigs developed skeletal muscle fasciculations. Muscle rigidity was not observed, however.
All MHS pigs ful®lled the MH criteria during the experiment. Body temperature increased by more than 2°C in all MHN pigs and Pa CO 2 exceeded 70 mm Hg in two MHN animals. Thus, two MHN pigs ful®lled the criteria of MH.
Comment
Lo Èscher and colleagues 5 studied the in vivo effects of the 5HT 2A receptor agonist DOI in conscious MHS pigs. In addition to altered behaviour, typical MH signs such as muscle rigidity and hyperthermia and metabolic changes such as elevated Pa CO 2 , lactate and creatinine kinase concentrations and lowered pH were observed in MHS but not in MHN pigs. Thus, DOI was interpreted as an MH triggering agent. Three underlying pathways may be responsible for the MH-like signs and symptoms after the administration of 5HT 2A agonists in conscious pigs. Firstly, direct substance-speci®c effects on peripheral sites, such as an activation of the skeletal muscle cell via 5HT 2A receptors resulting in an MH crisis could be responsible. A typical fulminant MH crisis is characterized by generalized fasciculations in MHS pigs.
6±8 Five min after the administration of trigger agents, hypercapnia, hypoxaemia, increased lactate concentrations and lowered pH are found. Cardiovascular responses include initial hypotension, tachycardia, increased cardiac output and arrhythmias. As a late sign of MH, a signi®cant increase in body temperature is not found until 10 min after exposure to a trigger substance. 8 Secondly, a porcine stress syndrome could be responsible. This syndrome describes MHS animals which are adversely affected by stress induced by trucking, ®ghting, coitus and crowding. 9 In this context, the hallucinogen-induced psychosis in conscious pigs might lead to a central stress induction, which secondarily results in the MH-like changes in skeletal muscle metabolism. The third hypothesis emphasizes a 5HT 2A -speci®c central agonist action, like the serotonin syndrome. 10 Our in vivo experiments did not show an unequivocal difference in the de®ned MH criteria in the study groups. Effects of a 5HT 2 agonist in MH-susceptible pigs Fasciculations and comparable increases in temperature, Pa CO 2 and a decline in pH were monitored after the ®rst and second challenge of DOI in both groups of pigs. However, differences in heart rate, pH and Pa CO 2 between MHS and MHN did not occur until the third dose of DOI.
The predictive value of our study may be reduced because the two groups of pigs had signi®cantly different weights. (There was no difference in age.) The weight difference could possibly explain the lower resting temperature in MHS compared with MHN pigs. In addition, a lower body temperature might be an MH-protective factor in pigs.
The results of the present study are in contrast to the typical course of MH in susceptible swine. Furthermore, the well-known trigger substances cannot induce MH in normal animals. It is notable that Lo Èscher and colleagues 5 described MH crises in conscious pigs at a lower concentration of DOI (0.8 mg kg ±1 ). Thus, it is tempting to speculate that different mechanisms are responsible for the induction of MH by 5HT 2A agonists and known MH trigger agents. The prolonged onset of clinical signs and symptoms, with similarity in the course of temperature, Pa CO 2 and pH in the two groups of pigs is in accordance with a serotonin syndrome. 10 Consequently, DOI does not seem to be a direct MH triggering agent in vivo in swine. However, 5HT 2A receptor agonists might secondarily trigger a porcine stress syndrome in conscious swine by inducing central psychotic alterations, which could be prevented by anaesthesia.
